Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy
Main Authors: | Saurabh Zanwar, Matthew Ho, Francis K. Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A. Gertz, Wilson Gonsalves, Ronald S. Go, Suzanne Hayman, Prashant Kapoor, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma Warsame, Amie Fonder, Miriam Hobbs, Yi L. Hwa, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-11-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-022-00752-z |
Similar Items
-
P885: SOLITARY PLASMACYTOMA: SINGLE INSTITUTION EXPERIENCE AND SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL OUTCOMES
by: Charalampos Charalampous, et al.
Published: (2023-08-01) -
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience
by: Sarah Goldman-Mazur, et al.
Published: (2022-12-01) -
Mode of progression in smoldering multiple myeloma: a study of 406 patients
by: Nadine H. Abdallah, et al.
Published: (2024-01-01) -
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide
by: Utkarsh Goel, et al.
Published: (2024-03-01) -
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma
by: Charalampos Charalampous, et al.
Published: (2023-12-01)